Divi's Laboratories rose 0.74% to Rs 994.50 at 11:55 IST on BSE after two block deals aggregating 4.50 lakh shares were executed on BSE at 10:39 IST.
One block deal of 1.12 lakh shares was executed at Rs 985 per share while another block deal of 3.38 lakh shares was executed at Rs 989.55 per share.
The two block deals constitute 0.33% of Divi's Laboratories' equity.
Meanwhile, the S&P BSE Sensex was down 14.32 points or 0.07% at 20,960.47.
On BSE, 4.56 lakh shares were traded in the counter as against average daily volume of 15,693 shares in the past one quarter.
The stock was volatile. The stock rose as much as 0.94% at the day's high of Rs 996.50 so far during the day. The stock lost as much as 0.21% at the day's low of Rs 985 so far during the day. The stock had hit a 52-week low of Rs 905 on 5 August 2013. The stock had hit a 52-week high of Rs 1,233 on 30 November 2012.
Also Read
The stock had underperformed the market over the past one month till 5 November 2013, declining 3.44% compared with the Sensex's 5.32% rise. The scrip had also underperformed the market in past one quarter, advancing 3.73% as against Sensex's 9.34% rise.
The large-cap company has equity capital of Rs 26.55 crore. Face value per share is Rs 2.
Divi's Laboratories' net profit rose 4.4% to Rs 174.71 crore on 10.1% growth in net sales to Rs 515.88 crore in Q1 June 2013 over Q1 June 2012. The company unveils Q2 September 2013 results on 8 November 2013.
Divi's Laboratories' product portfolio comprises generic active pharmaceutical ingredients (APIs) and custom synthesis of APIs, intermediates and specialty ingredients for innovator pharma giants. Custom synthesis also includes peptide building blocks (protected amino acids).
Powered by Capital Market - Live News